$2.12
-0.13-5.78%
In chiusura: -
$2.13
0.010000.47%
After hour: 7:52 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Inovio Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 10
Stima EPS
$-0.490
Stima dei ricavi trimestrali
$8.33K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$182.34K
Analizza lo storico degli utili di Inovio Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INO | Inovio Pharmaceuticals | -$0.89 | -$0.49 | — | — | $0.00 | $8.33K | — | — | 11/10/2025 | |
INO | Inovio Pharmaceuticals | -$1.19 | -$0.62 | -$0.61 | 1.61% | $100.76K | $25.00K | $0.00 | -100.00% | 08/12/2025 | |
INO | Inovio Pharmaceuticals | -$1.31 | -$0.74 | -$0.51 | 31.08% | $0.00 | $10.00K | $65.34K | 553.43% | 05/13/2025 | |
INO | Inovio Pharmaceuticals | -$1.10 | -$0.83 | -$0.65 | 21.69% | $103.00K | $25.00K | $117.00K | 368.00% | 03/18/2025 | |
INO | Inovio Pharmaceuticals | -$1.56 | -$1.13 | -$0.89 | 21.24% | $388.45K | $104.50K | $0.00 | -100.00% | 11/14/2024 | |
INO | Inovio Pharmaceuticals | -$1.61 | -$1.10 | -$1.19 | -8.18% | $225.97K | $120.00K | $100.76K | -16.03% | 08/08/2024 | |
INO | Inovio Pharmaceuticals | -$1.89 | -$1.00 | -$1.31 | -31.00% | $114.94K | — | $0.00 | — | 05/13/2024 | |
INO | Inovio Pharmaceuticals | -$2.64 | -$1.27 | -$1.10 | 13.39% | $125.00K | $340.00K | $103.00K | -69.71% | 03/06/2024 | |
INO | Inovio Pharmaceuticals | -$1.80 | -$1.56 | -$1.56 | 0.00% | $9.15M | $120.00K | $388.45K | 223.71% | 11/09/2023 | |
INO | Inovio Pharmaceuticals | -$5.52 | -$1.68 | -$1.56 | 7.14% | $784.39K | $260.00K | $225.97K | -13.09% | 08/09/2023 | |
INO | Inovio Pharmaceuticals | -$4.32 | -$1.68 | -$1.92 | -14.29% | $199.07K | $270.00K | $114.94K | -57.43% | 05/10/2023 | |
INO | Inovio Pharmaceuticals | -$6.00 | -$2.04 | -$2.64 | -29.41% | $839.00K | $340.00K | $125.00K | -63.24% | 03/01/2023 | |
INO | Inovio Pharmaceuticals | -$3.48 | -$3.60 | -$1.80 | 50.00% | $291.70K | $620.00K | $9.15M | 1376.45% | 11/08/2022 | |
INO | Inovio Pharmaceuticals | -$4.68 | -$3.72 | -$5.52 | -48.39% | $272.82K | $520.00K | $784.39K | 50.85% | 08/09/2022 | |
INO | Inovio Pharmaceuticals | -$3.24 | -$4.08 | -$4.32 | -5.88% | $371.12K | $670.00K | $199.07K | -70.29% | 05/10/2022 | |
INO | Inovio Pharmaceuticals | -$1.68 | -$3.84 | -$6.00 | -56.25% | $5.58M | $2.84M | $839.00K | -70.46% | 03/01/2022 | |
INO | Inovio Pharmaceuticals | -$3.12 | -$3.96 | -$3.48 | 12.12% | $236.18M | $970.00K | $291.70K | -69.93% | 11/09/2021 | |
INO | Inovio Pharmaceuticals | -$2.40 | -$3.00 | -$4.68 | -56.00% | $267.19K | $1.21M | $272.82K | -77.45% | 08/09/2021 | |
INO | Inovio Pharmaceuticals | -$3.12 | -$2.16 | -$3.24 | -50.00% | $1.33M | $850.00K | $371.12K | -56.34% | 05/10/2021 | |
INO | Inovio Pharmaceuticals | -$4.56 | -$2.64 | -$1.68 | 36.36% | $279.00K | $1.11M | $5.58M | 402.79% | 03/01/2021 | |
INO | Inovio Pharmaceuticals | -$3.00 | -$2.28 | -$3.12 | -36.84% | $866.86K | $3.05M | $236.18M | 7643.54% | 11/09/2020 |
Inovio Pharmaceuticals (INO) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.61 | $-0.62 | 1.61 % |
| Q1 | 2025-05-13 | $-0.51 | $-0.74 | 31.1 % |
| Q4 | 2025-03-18 | $-0.65 | $-0.83 | 21.7 % |
| Q3 | 2024-11-14 | $-0.89 | $-1.13 | 21.2 % |
Inovio Pharmaceuticals (INO) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $0 | $25.00K | -100.0 % |
| Q1 | 2025-05-13 | $65.34K | $10.00K | 553.4 % |
| Q4 | 2025-03-18 | $117.00K | $25.00K | 368.0 % |
| Q3 | 2024-11-14 | $0 | $104.50K | -100.0 % |
FAQ
Quando Inovio Pharmaceuticals (NASDAQ:INO) riporterà gli utili?
Si prevede che Inovio Pharmaceuticals (INO) fornisca risultati il novembre 10, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Inovio Pharmaceuticals (NASDAQ:INO)?
L'EPS effettivo era $-0.61, che superato la stima di $-0.62.
Quali sono state le entrate di Inovio Pharmaceuticals (NASDAQ:INO)?
Le entrate effettive sono state $0K, che mancato la stima di $25K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.